Depressive symptoms, antidepressant medication use, and insulin resistance: The PPP-Botnia study

30Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE - Although insulin resistance (IR) may underlie associations between depressive symptoms and diabetes, previous findings have been contradictory. We examined whether depressive symptoms associate with IR and insulin secretion, and, additionally, whether antidepressant medication use may modulate such associations. RESEARCH DESIGNANDMETHODS - A total of 4,419 individuals underwent an oral glucose tolerance test (OGTT). Participants with previously or newly diagnosed diabetes are excluded from this sample. The homeostasis model assessment of IR (HOMA-IR) and corrected insulin response (CIR) were calculated. Depressive symptoms and antidepressant medication use were self-reported. RESULTS - After controlling for confounding factors, depressive symptoms were associated with higher fasting and 30-min insulin during the OGTT and higher HOMA-IR but not CIR. Antidepressant medication use failed to modify these associations. CONCLUSIONS - Depressive symptoms are associated with IR but not with changes in insulin response when corrected for IR in individuals without previously or newly diagnosed diabetes. © 2011 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Pyykkönen, A. J., Räikkönen, K., Tuomi, T., Eriksson, J. G., Groop, L., & Isomaa, B. (2011). Depressive symptoms, antidepressant medication use, and insulin resistance: The PPP-Botnia study. Diabetes Care, 34(12), 2545–2547. https://doi.org/10.2337/dc11-0107

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free